Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Five Questions with Assured Research President William Wilt on What’s Trending in Auto and Workers’ Comp Today
We sat down with William Wilt, president of P&C industry research firm
Mitchell
News Release
Congress Makes Moves to Weed Out Marijuana Restrictions
After considering several marijuana-related bills, the US House passed HR 1595, the SAFE Banking Act on Wednesday, September 25, 2019.
Mitchell
News Release
Mitchell Announces Collaboration with Qualcomm Technologies to Enable XR Smart Glasses Solution for Collision Repair Facilities
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Blog
Beyond the Status Quo
We have been conditioned to expect that “best” equates to positive, desired results.
Mitchell
Article
Four Essential Investments for Improved Collision Repair Efficiency
What are the investments you can make in your repair shop to produce more in the same amount of time?
Workers' Comp
Blog
Medication-Assisted Treatment (MAT) Trends in 2018
Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compens